Eliminating viral hepatitis as a public health threat by 2030 is a target set under the UN Sustainable Development Goal on Health (SDG 3.3) (1). Ahead of World Hepatitis Day on 28 July, the EUDA has released today an update of its interactive elimination barometer designed to support countries in monitoring their progress towards the elimination of viral hepatitis among people who inject drugs.
Hepatitis C virus (HCV) infection is the infectious disease associated with the highest burden of disease among people who inject drugs (PWID), the virus being easily transmitted through the…
Čtěte více
This week, a delegation from the newly established European Union Drugs Agency (EUDA) visited Washington DC for a series of high-level meetings with US partners. Led by EUDA Executive Director Alexis Goosdeel, the delegation aimed to present the agency's new mandate and discuss potential areas of cooperation within its new responsibilities. This was the first EUDA visit to the US and took place just one week after the official inauguration of the agency in Lisbon. Following a meeting at the EU Delegation to the United States, the visiting EUDA staff members met with the following entities:…
Čtěte více
High-ranking officials are gathering in Lisbon today for the inauguration of the new European Union Drugs Agency (EUDA). The new agency replaces the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), which has been operating in Lisbon since 1995. New legislation which entered into application this week revises the EMCDDA mandate and name, and formally establishes the EUDA (1). The transformation marks a pivotal step in strengthening the EU’s capacity to address the health and security challenges posed by illicit drugs.
Following an external evaluation of the EMCDDA, the…
Čtěte více
